1887

Abstract

The existence of a mutual relationship between gut microbiota and immune homeostasis highlights its importance in the context of kidney transplantation.

The translational utility of gut microbiota as a biomarker for allograft injury has not been assessed before.

In this study, we aimed to characterize the gut microbial diversity in kidney transplant recipients and investigate the alterations in the gut microbial composition in association with allograft injury such as histopathological graft rejection and calcineurin inhibitor toxicity. In addition, we compared the gut microbial quantitation using 16S metagenomics and quantitative PCR (qPCR) to assess its translational utility.

In this prospective longitudinal cohort study, we enrolled 38 kidney transplant recipients and collected serial faecal specimens (=114), once before the induction therapy, and twice after transplant, during the first and third month. We characterized the gut microbial composition through 16S rRNA sequencing and qPCR from the DNA isolates of the samples. The recipients were clinically followed up for a median of 600 days post-transplant. Histopathological evidence of allograft rejection and calcineurin inhibitor toxicity were used for the correlational analysis with gut microbial diversity.

Significant differences in the gut microbial diversity were observed between the pre- and post-transplant samples. Pre-transplant gut microbiota revealed a higher relative abundance of phylum in the allograft rejection group, and a higher relative abundance of phylum was observed in the histopathological features of calcineurin inhibitor toxicity (hCNI toxicity) group. We found a high concordance between 16S metagenomics and qPCR outputs for assessing the gut microbial diversity. Furthermore, the receiver operating characteristic curve analysis has also proven that the pre-transplant levels of gut microbial dysbiosis, as a potential predictive biomarker for allograft injury.

Our pilot study found a strong statistical association of gut microbial dysbiosis with kidney allograft injury, highlighting the potential of gut microbiota as a predictive biomarker and that qPCR serves as a more reliable and economic tool for assessing dysbiosis paving the way for its translational utility.

Funding
This study was supported by the:
  • Jawaharlal Institute Of Postgraduate Medical Education and Research (Award JIP/IEC/2017/0115)
    • Principle Award Recipient: RajeshNachiappa Ganesh
  • Department of Biotechnology, Ministry of Science and Technology, India (Award BT/PR24816/MED/30/1902/2017)
    • Principle Award Recipient: RajeshNachiappa Ganesh
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001934
2024-11-14
2024-12-08
Loading full text...

Full text loading...

References

  1. Hajjo R, Sabbah DA, Al Bawab AQ. Unlocking the potential of the human microbiome for identifying disease diagnostic biomarkers. Diagnostics 2022; 12:1742 [View Article] [PubMed]
    [Google Scholar]
  2. Rinninella E, Raoul P, Cintoni M, Franceschi F, Miggiano GAD et al. What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms 2019; 7:14 [View Article] [PubMed]
    [Google Scholar]
  3. Stojanov S, Berlec A, Štrukelj B. The influence of probiotics on the firmicutes/bacteroidetes ratio in the treatment of obesity and inflammatory bowel disease. Microorganisms 2020; 8:1715 [View Article] [PubMed]
    [Google Scholar]
  4. Kumar S, Kumar A. Microbial pathogenesis in inflammatory bowel diseases. Microb Pathog 2022; 163:105383 [View Article] [PubMed]
    [Google Scholar]
  5. Al Bataineh MT, Alzaatreh A, Hajjo R, Banimfreg BH, Dash NR. Compositional changes in human gut microbiota reveal a putative role of intestinal mycobiota in metabolic and biological decline during aging. Nutr Healthy Aging 2021; 6:269–283 [View Article]
    [Google Scholar]
  6. Michaudel C, Sokol H. The gut microbiota at the service of immunometabolism. Cell Metabolism 2020; 32:514–523 [View Article]
    [Google Scholar]
  7. Yoo JY, Groer M, Dutra SVO, Sarkar A, McSkimming DI. Gut microbiota and immune system interactions. Microorganisms 2020; 8: [View Article]
    [Google Scholar]
  8. Nallu A, Sharma S, Ramezani A, Muralidharan J, Raj D. Gut microbiome in chronic kidney disease: challenges and opportunities. Transl Res 2017; 179:24–37 [View Article] [PubMed]
    [Google Scholar]
  9. Naik RH SS Renal transplantation rejection. In StatPearls [Internet] Treasure Island (FL): StatPearls publishing 2024. PMID:31971715; 2023
    [Google Scholar]
  10. Farouk SS, Rein JL. The many faces of calcineurin inhibitor toxicity—What the FK?. Adv Chronic Kidney Dis 2020; 27:56–66 [View Article]
    [Google Scholar]
  11. Ahmad S, Bromberg JS. Current status of the microbiome in renal transplantation. Curr Opin Nephrol Hypertens 2016; 25:570–576 [View Article] [PubMed]
    [Google Scholar]
  12. Ardalan M, Vahed SZ. Gut microbiota and renal transplant outcome. Biomed Pharmacother 2017; 90:229–236 [View Article] [PubMed]
    [Google Scholar]
  13. Gabarre P, Loens C, Tamzali Y, Barrou B, Jaisser F et al. Immunosuppressive therapy after solid organ transplantation and the gut microbiota: bidirectional interactions with clinical consequences. Am J Transplant 2022; 22:1014–1030 [View Article] [PubMed]
    [Google Scholar]
  14. Huang P, Cao J, Chen J, Luo Y, Gong X et al. Crosstalk between gut microbiota and renal ischemia/reperfusion injury. Front Cell Infect Microbiol 2022; 12:1015825 [View Article] [PubMed]
    [Google Scholar]
  15. García-Martínez Y, Borriello M, Capolongo G, Ingrosso D, Perna AF. The gut microbiota in kidney transplantation: A target for personalized therapy?. Biology 2023; 12:163 [View Article] [PubMed]
    [Google Scholar]
  16. Fricke WF, Maddox C, Song Y, Bromberg JS. Human microbiota characterization in the course of renal transplantation. Am J Transplant 2014; 14:416–427 [View Article] [PubMed]
    [Google Scholar]
  17. Lee JR, Muthukumar T, Dadhania D, Toussaint NC, Ling L et al. Gut microbial community structure and complications after kidney transplantation: A pilot study. Transplantation 2014; 98:697–705 [View Article] [PubMed]
    [Google Scholar]
  18. Claesson MJ, O’Sullivan O, Wang Q, Nikkilä J, Marchesi JR et al. Comparative analysis of pyrosequencing and a phylogenetic microarray for exploring microbial community structures in the human distal intestine. PLoS One 2009; 4:e6669 [View Article]
    [Google Scholar]
  19. van den Bogert B, de Vos WM, Zoetendal EG, Kleerebezem M. Microarray analysis and barcoded pyrosequencing provide consistent microbial profiles depending on the source of human intestinal samples. Appl Environ Microbiol 2011; 77:2071–2080 [View Article] [PubMed]
    [Google Scholar]
  20. Wu W-K, Chen C-C, Panyod S, Chen R-A, Wu M-S et al. Optimization of fecal sample processing for microbiome study - The journey from bathroom to bench. J Formos Med Assoc 2019; 118:545–555 [View Article] [PubMed]
    [Google Scholar]
  21. Wesolowska-Andersen A, Bahl MI, Carvalho V, Kristiansen K, Sicheritz-Pontén T et al. Choice of bacterial DNA extraction method from fecal material influences community structure as evaluated by metagenomic analysis. Microbiome 2014; 2:19 [View Article] [PubMed]
    [Google Scholar]
  22. Carroll IM, Ringel-Kulka T, Siddle JP, Ringel Y. Characterization of the fecal microbiota using high-throughput sequencing reveals a stable microbial community during storage. PLoS One 2012; 7:e46953 [View Article] [PubMed]
    [Google Scholar]
  23. Seo J-W, Moon H, Kim S-Y, Moon J-Y, Jeong KH et al. Both absolute and relative quantification of urinary mRNA are useful for non-invasive diagnosis of acute kidney allograft rejection. PLoS One 2017; 12:e0180045 [View Article] [PubMed]
    [Google Scholar]
  24. Roufosse C, Simmonds N, Clahsen-van Groningen M, Haas M, Henriksen KJ et al. A 2018 reference guide to the banff classification of renal allograft pathology. Transplantation 2018; 102:1795–1814 [View Article] [PubMed]
    [Google Scholar]
  25. Yu DH, Ying N, Lian ZH, Fa YQ. The alteration human of gut microbiota and metabolites before and after renal transplantation. Microb Pathog 2021; 160:105191 [View Article] [PubMed]
    [Google Scholar]
  26. Guirong YE, Minjie Z, Lixin YU, Junsheng YE, Lin Y et al. Gut microbiota in renal transplant recipients, patients with chronic kidney disease and healthy subjects. Nan Fang Yi Ke Da Xue Xue Bao 2018; 38:1401–1408 [View Article] [PubMed]
    [Google Scholar]
  27. Souai N, Zidi O, Mosbah A, Kosai I, Manaa JE et al. Impact of the post-transplant period and lifestyle diseases on human gut microbiota in kidney graft recipients. Microorganisms 2020; 8:1724 [View Article] [PubMed]
    [Google Scholar]
  28. Swarte JC, Douwes RM, Hu S, Vich Vila A, Eisenga MF et al. Characteristics and dysbiosis of the gut microbiome in renal transplant recipients. J Clin Med 2020; 9:386 [View Article] [PubMed]
    [Google Scholar]
  29. Oh PL, Martínez I, Sun Y, Walter J, Peterson DA et al. Characterization of the ileal microbiota in rejecting and nonrejecting recipients of small bowel transplants. Am J Transplant 2012; 12:753–762 [View Article] [PubMed]
    [Google Scholar]
  30. Dickson RP, Erb-Downward JR, Freeman CM, Walker N, Scales BS et al. Changes in the lung microbiome following lung transplantation include the emergence of two distinct Pseudomonas species with distinct clinical associations. PLoS One 2014; 9:e97214 [View Article]
    [Google Scholar]
  31. Kim B-R, Shin J, Guevarra R, Lee JH, Kim DW et al. Deciphering diversity indices for a better understanding of microbial communities. J Microbiol Biotechnol 2017; 27:2089–2093 [View Article] [PubMed]
    [Google Scholar]
  32. Yin L, Wan Y-D, Pan X-T, Zhou C-Y, Lin N et al. Association between gut bacterial diversity and mortality in septic shock patients: A cohort study. Med Sci Monit 2019; 25:7376–7382 [View Article] [PubMed]
    [Google Scholar]
  33. Lee JR, Muthukumar T, Dadhania D, Taur Y, Jenq RR et al. Gut microbiota and tacrolimus dosing in kidney transplantation. PLoS One 2015; 10:e0122399 [View Article]
    [Google Scholar]
  34. Jian C, Luukkonen P, Yki-Järvinen H, Salonen A, Korpela K. Quantitative PCR provides a simple and accessible method for quantitative microbiota profiling. PLoS One 2020; 15:e0227285 [View Article] [PubMed]
    [Google Scholar]
/content/journal/jmm/10.1099/jmm.0.001934
Loading
/content/journal/jmm/10.1099/jmm.0.001934
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error